New York, USA – August 28, 2020 – Creative Proteomics (CP), the leading US edge proteomics testing and analysis services provider, recently launched a new website to the scientific community, precision medicine, pharmaceutical and biotechnology industries.
The newly established website, known as Creative Proteomics GutFlora Omics, combines CP’s leadership in providing critical research tools and integrated support services supporting drug discovery and development, with its world-recognized expertise in proteomics.
The company’s services will be powered by several proprietary integrated discovery platforms:
1. NGS Platform
The NGS platform delivers exceptional data quality and accuracy at a massive scale, propelling unprecedented progress in clients’ gut microbiota research projects. A wide range of sequencing services for gut microbiota, including amplicon sequencing, whole-genome sequencing, metagenomic sequencing, metatranscriptomic sequencing, and more are available.
2. Mass Spectrometry Platforms
The Mass Spectrometry Platforms include mass spectrometer, tandem mass spectrometry (MS/MS), and electrospray ionization mass spectrometry (ESI-MS). It can be practiced on multiple and versatile platforms, each has its specialties with regard to different sample types and data requirements. Those platforms guarantee high quality and high coverage, which offers an accurate and comprehensive view of data-intensive analysis with respect to gut microbiota metaproteomics and metabolomics.
With those proprietary platforms, bioinformatics analysis and other methods, Creative Proteomics offers gut microbiota multi-omics solutions, including (meta) genomics, (meta) transcriptomics, (meta) proteomics and metabolomics to facilitate researches of gut microbiome.
The company has been focused on gut microbiome for years, aiming to provide the best services for its academic and industrial customers to achieve their success. Here is a list of solutions:
• Gut Microbiome and Host Homeostasis• Targeted Monitoring of Gut Microbiota• Gut Microbiota and Diseases• Gut Microbiota in Therapeutic and Diagnostic Research
About Creative Proteomics
Creative Proteomics, established in 2004, based in Shirley, New York, is an innovative provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Creative Proteomics has gradually developed into an integrated company that provides multi-omics and bioinformatics analysis services to researchers in the pharmaceutical, biotechnology, agriculture and nutrition industries, as well as academic and government organizations. With a continuing focus on quality.
For more information, please visit the website at https://gutfloraomics.creative-proteomics.com.
Media ContactCompany Name: Creative ProteomicsContact Person: Melisa GeogerEmail: Send EmailPhone: 1-631-619-7922Country: United StatesWebsite: https://gutfloraomics.creative-proteomics.com